• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在公共发展伙伴关系中努力研发新的抗寄生虫药物。

Working towards New Drugs against Parasitic Worms in a Public-Development Partnership.

机构信息

Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia; Faculty of Science and Technology, Federation University, Ballarat, Victoria 3350, Australia.

Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia.

出版信息

Trends Parasitol. 2018 Jan;34(1):4-6. doi: 10.1016/j.pt.2017.07.005. Epub 2017 Aug 4.

DOI:10.1016/j.pt.2017.07.005
PMID:28784352
Abstract

There is a clear need to develop new and inexpensive drugs to alleviate diseases caused by parasitic worms in animals and humans worldwide. In this article we discuss the roles and advantages of working in public-private partnerships (PPPs) - among academia, industry, and philanthropy - to enable anthelmintic drug discovery.

摘要

显然需要开发新的、廉价的药物来缓解全球动物和人类寄生虫引起的疾病。本文讨论了学术界、工业界和慈善界之间开展公私合作伙伴关系(PPP)的作用和优势,以促进驱虫药物的发现。

相似文献

1
Working towards New Drugs against Parasitic Worms in a Public-Development Partnership.在公共发展伙伴关系中努力研发新的抗寄生虫药物。
Trends Parasitol. 2018 Jan;34(1):4-6. doi: 10.1016/j.pt.2017.07.005. Epub 2017 Aug 4.
2
Anthelmintic drug discovery: into the future.抗寄生虫药物研发:展望未来。
J Parasitol. 2015 Apr;101(2):125-33. doi: 10.1645/14-703.1. Epub 2015 Jan 13.
3
A new approach for anthelmintic discovery for humans.一种针对人类的驱虫药物新发现方法。
Trends Parasitol. 2012 May;28(5):176-81. doi: 10.1016/j.pt.2012.02.006. Epub 2012 Mar 15.
4
Overcoming the current deadlock in antibiotic research.克服抗生素研究当前的僵局。
Trends Microbiol. 2014 Apr;22(4):165-7. doi: 10.1016/j.tim.2013.12.007.
5
Whole-organism phenotypic screening methods used in early-phase anthelmintic drug discovery.用于早期驱虫药发现的全生物体表型筛选方法。
Biotechnol Adv. 2022 Jul-Aug;57:107937. doi: 10.1016/j.biotechadv.2022.107937. Epub 2022 Mar 7.
6
Partnerships for better neglected disease drug discovery and development: how have we fared?加强被忽视疾病药物研发的伙伴关系:我们做得如何?
Expert Opin Drug Discov. 2020 May;15(5):531-537. doi: 10.1080/17460441.2020.1736550. Epub 2020 Mar 10.
7
The drugs we have and the drugs we need against major helminth infections.针对主要寄生虫感染的现有药物和所需药物。
Adv Parasitol. 2010;73:197-230. doi: 10.1016/S0065-308X(10)73008-6.
8
Worms--a "license to kill".蠕虫——“杀戮许可证”。
Vet Parasitol. 2013 Aug 1;195(3-4):286-91. doi: 10.1016/j.vetpar.2013.04.009. Epub 2013 Apr 6.
9
Anthelmintics: From discovery to resistance II (San Diego, 2016).驱虫药:从发现到抗药性 II(圣地亚哥,2016 年)
Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):297-298. doi: 10.1016/j.ijpddr.2016.09.002. Epub 2016 Sep 29.
10
Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development.公私合作伙伴关系:药物发现和开发中的化合物和数据共享。
SLAS Discov. 2021 Jun;26(5):604-619. doi: 10.1177/2472555220982268. Epub 2021 Feb 13.

引用本文的文献

1
Progress, impacts and lessons from market shaping in the past decade: a systematic review.过去十年市场塑造的进展、影响及经验教训:一项系统综述
Front Public Health. 2025 Aug 21;13:1614471. doi: 10.3389/fpubh.2025.1614471. eCollection 2025.
2
Prediction and Prioritisation of Novel Anthelmintic Candidates from Public Databases Using Deep Learning and Available Bioactivity Data Sets.利用深度学习和现有生物活性数据集从公共数据库中预测新型驱虫候选物并进行优先级排序。
Int J Mol Sci. 2025 Mar 28;26(7):3134. doi: 10.3390/ijms26073134.
3
High-Throughput Phenotypic Assay to Screen for Anthelmintic Activity on .
高通量表型分析用于筛选对……的驱虫活性
Pharmaceuticals (Basel). 2021 Jun 26;14(7):616. doi: 10.3390/ph14070616.
4
Three Small Molecule Entities (MPK18, MPK334 and YAK308) with Activity against In Vitro.三种小分子实体(MPK18、MPK334 和 YAK308)对体外具有活性。
Molecules. 2021 May 10;26(9):2819. doi: 10.3390/molecules26092819.
5
A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis.一种用于鉴定新型利什曼原虫主要蛋白二硫键异构酶抑制剂以治疗利什曼病的计算机辅助方法。
J Comput Aided Mol Des. 2021 Mar;35(3):297-314. doi: 10.1007/s10822-021-00374-w. Epub 2021 Feb 22.
6
Development of a Solid Formulation Containing a Microemulsion of a Novel Extract with Nematocidal Activity for Oral Administration.一种含具有杀线虫活性的新型提取物微乳剂的口服固体剂型的研发。
Pharmaceutics. 2020 Sep 14;12(9):873. doi: 10.3390/pharmaceutics12090873.
7
Chemoinformatics Strategies for Leishmaniasis Drug Discovery.用于利什曼病药物发现的化学信息学策略
Front Pharmacol. 2018 Nov 1;9:1278. doi: 10.3389/fphar.2018.01278. eCollection 2018.
8
Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni.筛选疟疾药物 Venture 停滞盒再利用文库,对抗曼氏血吸虫。
Parasit Vectors. 2018 May 15;11(1):298. doi: 10.1186/s13071-018-2855-z.